Addition of exenatide or sitagliptin to insulin in new onset type 1 diabetes: A randomized, open label study

References

Page 1

	Year	Citations
Intensive Diabetes Treatment and Cardiovascular Disease in Patients with Type 1 Diabetes New England Journal of Medicine	2005	5.1K
The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study at 30 Years: Overview David M. Nathan Diabetes Care	2013	1.8K
Efficacy and safety of sitagliptin when added to insulin therapy in patients with type 2 diabetes Tina Vilsbøll, Julio Rosenstock, H Yki-Järvinen, Diabetes Obesity and Metabolism	2009	303
Proinsulin peptide immunotherapy in type 1 diabetes: report of a first-in-man Phase I safety study Sally Thrower, Louisa K. James, Wayne Hall, Clinical & Experimental Immunology	2008	148
Effects of Exenatide Alone and in Combination With Daclizumab on β-Cell Function in Long-Standing Type 1 Diabetes Kristina I. Rother, Lisa M. Spain, Robert Wesley, Diabetes Care	2009	131
Exendin-4 Normalized Postcibal Glycemic Excursions in Type 1 Diabetes John Dupré, Margaret T. Behme, Thomas J. McDonald The Journal of Clinical Endocrinology & Metabolism Metabolic SyndromeType 1Diabetes ManagementMedicineReptilian Peptide	2004	129
Liraglutide as additional treatment for type 1 diabetes Ajay Varanasi, Natalie J. Bellini, Deepti Rawal, European Journal of Endocrinology	2011	129
Reversal of New-Onset Diabetes through Modulating Inflammation and Stimulating β-Cell Replication in Nonobese Diabetic Mice by a Dipeptidyl Peptidase IV Inhibitor Lei Tian, Jie Gao, Jianqiang Hao, Endocrinology	2010	118
Natural Course of Remission in IDDM During 1st yr After Diagnosis S Martin, Brigette Pawlowski, B. Greulich, Diabetes Care	1992	103
The Role of Adjunctive Exenatide Therapy in Pediatric Type 1 Diabetes Vandana Raman, Kimberly Mason, Luisa M. Rodríguez, Diabetes Care Diabetes ManagementAdjunctive Exenatide TherapyInsulin ManagementDiabetesPharmacology	2010	85

Page 1